Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups (Q64040669)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups |
clinical trial |
Statements
An Open-Label Phase 3 Study to Assess the Safety and Immunogenicity of a Vero Cell-Derived Whole Virus H5N1 Influenza Vaccine in an Adult and Elderly Population as Well as in Specified Risk Groups (English)
0 references
August 2008
0 references
July 2009
0 references
3,583
0 references
18 year
0 references